4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / The Effect of Intraoperative Use of Dexmedetomidine During the Daytime Operation vs the Nighttime Operation on Postoperative Sleep Quality and Pain Under General Anesthesia

The Effect of Intraoperative Use of Dexmedetomidine During the Daytime Operation vs the Nighttime Operation on Postoperative Sleep Quality and Pain Under General Anesthesia

Study Description
Brief Summary:
General anesthesia is a medically induced state of low reactivity consciousness which is similar to natural sleep. Some studies found that general anesthesia as an independent risk factor could result in a desynchronization of the circadian time structure and cause postoperative sleep disorders characterized by reduced rapid eye movement (REM) and slow wave sleep (SWS), which have significant deleterious impacts on postoperative outcomes, such as postoperative fatigue, severe anxiety and depression, emotional detachment and delirium, and even pain sensitivity or postoperative pain of patients.Clinical trials have already proved that intraoperative use of dexmedetomidine (DEX) for general anesthesia, a highly selective alpha-2 adrenergic agonist, was able to improve sedative and analgesia effects and promote sleep quality (by decreasing stage N1 sleep, increasing stage N2 sleep and sleep efficiency). However, Wenfei Tan et al reported that with the deeper sedative state provided by DEX in the daytime, the elderly male patients undergoing TURP under spinal anesthesia suffered worse sleep on the night of surgery. Thus, what the effect of intraoperative using DEX at different time periods under general anesthesia on postoperative sleep quality and pain will be needs further study.

Condition or disease Intervention/treatment
Postoperative Pain Postoperative Sleep Quality Intraoperative Dexmedetomidine General Anesthesia Other: time of receiving operation

Detailed Description:
patients scheduled for elective laparoscopic abdominal surgeries under general anesthesia were enrolled. Patients were randomized to receive operation in the D group (8:00-12:00) and the N group (18:00-22:00). The Portable Sleep Monitor (PSM) was performed on the following 3 nights: the night before surgery (Sleep1), the first night after surgery (Sleep 2), and the third night after surgery (Sleep 3). Postoperative pain scores using visual analogue scoring scale, subjective sleep quality using the Athens Insomnia Scale, total dose of general anesthetics and PCA pump press numbers were also recorded.
Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 75 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: The Effect of Intraoperative Use of Dexmedetomidine During the Daytime Operation vs the Nighttime Operation on Postoperative Sleep Quality and Pain Under General Anesthesia
Actual Study Start Date : June 15, 2019
Estimated Primary Completion Date : November 30, 2019
Estimated Study Completion Date : December 31, 2019
Arms and Interventions
Group/Cohort Intervention/treatment
Day group
patients in Day group accept operation from 8:00~12:00
Other: time of receiving operation
patients were randomly divided into Day group (D group) (8:00~12:00) and Night group (N group) (18:00~22:00), Patients received propofol, remifentanil, and DEX for general anesthesia maintenance

Night group
patients in Night group accept operation from 18:00~22:00
Other: time of receiving operation
patients were randomly divided into Day group (D group) (8:00~12:00) and Night group (N group) (18:00~22:00), Patients received propofol, remifentanil, and DEX for general anesthesia maintenance

Outcome Measures
Primary Outcome Measures :
  1. Sleep quality of one night before the surgery [ Time Frame: one night before the surgery ]
    Use sleep monitor to test the sleep quality on one night before the surgery

  2. Sleep quality of first night after the surgery [ Time Frame: the first night after the surgery ]
    Use sleep monitor to test the sleep quality on the first night after the surgery

  3. Sleep quality of third night after the surgery [ Time Frame: the third night after the surgery ]
    Use sleep monitor to test the sleep quality on the third night after the surgery


Secondary Outcome Measures :
  1. Visual analog scale (VAS) [ Time Frame: 1,6,24,48 hours after the surgery ]
    Evaluate the VAS score at 1,6,24,48 hours after the surgery.Visual analog scale (VAS) score of 0 was considered painless, and a score of 10 was considered as intense pain. Scores of 4 and below were considered mild pain (pain does not affect sleep), and scores of 5 to 6 were considered moderate pain (pain influences sleep, but the patients can still fall asleep). Scores of 7 and above were considered severe pain (Due to the pain the patient is unable to sleep or wakes up)

  2. PCA pump press number [ Time Frame: 48 hours after the surgery ]
    Evaluate the Pump press number 48 hours after the surgery


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   30 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who underwent elective laparoscopic abdominal surgeries under general anesthesia at Shengjing Hospital of China Medical University were enrolled in this study
Criteria

Inclusion Criteria:

age between 30 and 55 years American Society of Anaesthesiologists physical status I or II.

Exclusion Criteria:

cardiovascular disease long term use of analgesia preoperative heart rate (HR) less than 50 beats/min second- or third-degree atrioventricular block sleep disorder sleep apnea syndrome history of abnormal operation or anesthesia recovery psychosis or a patient with a language communication disorder not willing to cooperate with the experimenter.

Contacts and Locations

Contacts
Layout table for location contacts
Contact: bijia Song 18309845273 ext 18309845273 630992254@qq.com
Contact: Junchao Zhu 18940257257 ext 18940257257 zhujunchao1@hotmail.com

Locations
Layout table for location information
China, Liao Ning
shengjing hospital of China medical university Recruiting
Shenyang, Liao Ning, China, 110004
Contact: Zhu junchao, doctor    18940257257    zhujunchao1@hotmail.com   
Contact: Song bijia, master    18309845273    630992254@qq.com   
Sponsors and Collaborators
Shengjing Hospital
Investigators
Layout table for investigator information
Study Director: Junchao Zhu Shengjing Hospital
Tracking Information
First Submitted Date June 11, 2019
First Posted Date June 19, 2019
Last Update Posted Date September 19, 2019
Actual Study Start Date June 15, 2019
Estimated Primary Completion Date November 30, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 16, 2019)
  • Sleep quality of one night before the surgery [ Time Frame: one night before the surgery ]
    Use sleep monitor to test the sleep quality on one night before the surgery
  • Sleep quality of first night after the surgery [ Time Frame: the first night after the surgery ]
    Use sleep monitor to test the sleep quality on the first night after the surgery
  • Sleep quality of third night after the surgery [ Time Frame: the third night after the surgery ]
    Use sleep monitor to test the sleep quality on the third night after the surgery
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: July 27, 2019)
  • Visual analog scale (VAS) [ Time Frame: 1,6,24,48 hours after the surgery ]
    Evaluate the VAS score at 1,6,24,48 hours after the surgery.Visual analog scale (VAS) score of 0 was considered painless, and a score of 10 was considered as intense pain. Scores of 4 and below were considered mild pain (pain does not affect sleep), and scores of 5 to 6 were considered moderate pain (pain influences sleep, but the patients can still fall asleep). Scores of 7 and above were considered severe pain (Due to the pain the patient is unable to sleep or wakes up)
  • PCA pump press number [ Time Frame: 48 hours after the surgery ]
    Evaluate the Pump press number 48 hours after the surgery
Original Secondary Outcome Measures
 (submitted: June 16, 2019)
  • Visual analog scale (VAS) [ Time Frame: 1,6,24,48 hours after the surgery ]
    Evaluate the VAS score at 1,6,24,48 hours after the surgery.Visual analog scale (VAS) score of 0 was considered painless, and a score of 10 was considered as intense pain. Scores of 4 and below were considered mild pain (pain does not affect sleep), and scores of 5 to 6 were considered moderate pain (pain influences sleep, but the patients can still fall asleep). Scores of 7 and above were considered severe pain (Due to the pain the patient is unable to sleep or wakes up)
  • sufentanil consumption [ Time Frame: 1,6,24,48hours after the surgery ]
    Evaluate the sufentanil consumption at 1,6,24,48hours after the surgery. Sufentanil Consumption means PCA pump press number * 5ml+(48-PCA pump press number*15/60)*2ml
  • PCA pump press number [ Time Frame: 1,6,24,48hours after the surgery ]
    Evaluate the Pump press number at 1,6,24,48hours after the surgery
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title The Effect of Intraoperative Use of Dexmedetomidine During the Daytime Operation vs the Nighttime Operation on Postoperative Sleep Quality and Pain Under General Anesthesia
Official Title The Effect of Intraoperative Use of Dexmedetomidine During the Daytime Operation vs the Nighttime Operation on Postoperative Sleep Quality and Pain Under General Anesthesia
Brief Summary General anesthesia is a medically induced state of low reactivity consciousness which is similar to natural sleep. Some studies found that general anesthesia as an independent risk factor could result in a desynchronization of the circadian time structure and cause postoperative sleep disorders characterized by reduced rapid eye movement (REM) and slow wave sleep (SWS), which have significant deleterious impacts on postoperative outcomes, such as postoperative fatigue, severe anxiety and depression, emotional detachment and delirium, and even pain sensitivity or postoperative pain of patients.Clinical trials have already proved that intraoperative use of dexmedetomidine (DEX) for general anesthesia, a highly selective alpha-2 adrenergic agonist, was able to improve sedative and analgesia effects and promote sleep quality (by decreasing stage N1 sleep, increasing stage N2 sleep and sleep efficiency). However, Wenfei Tan et al reported that with the deeper sedative state provided by DEX in the daytime, the elderly male patients undergoing TURP under spinal anesthesia suffered worse sleep on the night of surgery. Thus, what the effect of intraoperative using DEX at different time periods under general anesthesia on postoperative sleep quality and pain will be needs further study.
Detailed Description patients scheduled for elective laparoscopic abdominal surgeries under general anesthesia were enrolled. Patients were randomized to receive operation in the D group (8:00-12:00) and the N group (18:00-22:00). The Portable Sleep Monitor (PSM) was performed on the following 3 nights: the night before surgery (Sleep1), the first night after surgery (Sleep 2), and the third night after surgery (Sleep 3). Postoperative pain scores using visual analogue scoring scale, subjective sleep quality using the Athens Insomnia Scale, total dose of general anesthetics and PCA pump press numbers were also recorded.
Study Type Observational
Study Design Observational Model: Other
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patients who underwent elective laparoscopic abdominal surgeries under general anesthesia at Shengjing Hospital of China Medical University were enrolled in this study
Condition
  • Postoperative Pain
  • Postoperative Sleep Quality
  • Intraoperative Dexmedetomidine
  • General Anesthesia
Intervention Other: time of receiving operation
patients were randomly divided into Day group (D group) (8:00~12:00) and Night group (N group) (18:00~22:00), Patients received propofol, remifentanil, and DEX for general anesthesia maintenance
Study Groups/Cohorts
  • Day group
    patients in Day group accept operation from 8:00~12:00
    Intervention: Other: time of receiving operation
  • Night group
    patients in Night group accept operation from 18:00~22:00
    Intervention: Other: time of receiving operation
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: September 17, 2019)
75
Original Estimated Enrollment
 (submitted: June 16, 2019)
80
Estimated Study Completion Date December 31, 2019
Estimated Primary Completion Date November 30, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

age between 30 and 55 years American Society of Anaesthesiologists physical status I or II.

Exclusion Criteria:

cardiovascular disease long term use of analgesia preoperative heart rate (HR) less than 50 beats/min second- or third-degree atrioventricular block sleep disorder sleep apnea syndrome history of abnormal operation or anesthesia recovery psychosis or a patient with a language communication disorder not willing to cooperate with the experimenter.

Sex/Gender
Sexes Eligible for Study: All
Ages 30 Years to 55 Years   (Adult)
Accepts Healthy Volunteers No
Contacts
Contact: bijia Song 18309845273 ext 18309845273 630992254@qq.com
Contact: Junchao Zhu 18940257257 ext 18940257257 zhujunchao1@hotmail.com
Listed Location Countries China
Removed Location Countries  
 
Administrative Information
NCT Number NCT03990987
Other Study ID Numbers Dexmedetomidine and sleep
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement Not Provided
Responsible Party Yanchao Yang, Shengjing Hospital
Study Sponsor Shengjing Hospital
Collaborators Not Provided
Investigators
Study Director: Junchao Zhu Shengjing Hospital
PRS Account Shengjing Hospital
Verification Date July 2019